Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Critics of longtermism say it appeals to wealthy tech moguls precisely because it adds a sheen of morality to their ...

Credo Technology thrives on AI infrastructure demand and Nvidia's success but faces valuation and risk concerns. Read what to ...

The US Court of International Trade has voted to block the implementation of the majority of President Trump's global tariffs ...

The U.S. government is pulling its funding for drugmaker Moderna to continue testing an mRNA vaccine intended to protect people from the bird flu.

More than $14 billion in clean energy investments in the U.S. have been canceled or delayed this year, according to an ...

Bruce just purchased a 2025 Toyota RAV4, and he's ready to trade it in. He has several reasons why he dislikes the new small ...

Community participation emerges as a fundamental pillar in addressing the escalating challenge of juvenile delinquency across ...

REDMOND, WA / ACCESS Newswire / May 28, 2025 / MicroVision, Inc. , a technology pioneer delivering advanced perception solutions in autonomy and mobility, today published an open letter to ...

Office-based surgery started with the idea that patients undergoing cataract surgery should have the same experience as those ...

Network Rail is working in partnership with the major rail firms as they attempt to tackle the tragic loss of life. In the ...

Conclusion U.S. markets rebounded strongly as trade tensions eased, but investors remain alert to upcoming monetary policy ...